These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
143 related articles for article (PubMed ID: 24507386)
1. Combination therapy of anti-cancer bioactive peptide with Cisplatin decreases chemotherapy dosing and toxicity to improve the quality of life in xenograft nude mice bearing human gastric cancer. Su X; Dong C; Zhang J; Su L; Wang X; Cui H; Chen Z Cell Biosci; 2014 Feb; 4(1):7. PubMed ID: 24507386 [TBL] [Abstract][Full Text] [Related]
2. Anticancer bioactive peptide-3 inhibits human gastric cancer growth by suppressing gastric cancer stem cells. Yu L; Yang L; An W; Su X J Cell Biochem; 2014 Apr; 115(4):697-711. PubMed ID: 24214799 [TBL] [Abstract][Full Text] [Related]
3. New bioactive peptide reduces the toxicity of chemotherapy drugs and increases drug sensitivity. Li X; Wu H; Ouyang X; Zhang B; Su X Oncol Rep; 2017 Jul; 38(1):129-140. PubMed ID: 28560442 [TBL] [Abstract][Full Text] [Related]
4. [Effect of ACBP-S on cell cycle and apoptosis in human gastric cancer cells]. Su XL; Ouyang XH; Xu GH; Shen J; Wang ZY Zhonghua Zhong Liu Za Zhi; 2008 Jun; 30(6):422-7. PubMed ID: 19024515 [TBL] [Abstract][Full Text] [Related]
5. Bioactive Peptides Sensitize Cells to Anticancer Effects of Oxaliplatin in Human Colorectal Cancer Xenografts in Nude Mice. Li X; Xia L; Ouyang X; Suyila Q; Su L; Su X Protein Pept Lett; 2019; 26(7):512-522. PubMed ID: 30950338 [TBL] [Abstract][Full Text] [Related]
6. Anticancer bioactive peptide combined with docetaxel and its mechanism in the treatment of breast cancer. Li X; Gao B; Su X Exp Ther Med; 2020 Sep; 20(3):1917-1924. PubMed ID: 32782500 [TBL] [Abstract][Full Text] [Related]
7. Anticancer bioactive peptide suppresses human gastric cancer growth through modulation of apoptosis and the cell cycle. Su L; Xu G; Shen J; Tuo Y; Zhang X; Jia S; Chen Z; Su X Oncol Rep; 2010 Jan; 23(1):3-9. PubMed ID: 19956858 [TBL] [Abstract][Full Text] [Related]
8. Anticancer bioactive peptide-3 inhibits human gastric cancer growth by targeting miR-338-5p. Xing Z; Yu L; Li X; Su X Cell Biosci; 2016; 6():53. PubMed ID: 27688872 [TBL] [Abstract][Full Text] [Related]
9. Anticancer bioactive peptide (ACBP) inhibits gastric cancer cells by upregulating growth arrest and DNA damage-inducible gene 45A (GADD45A). Su LY; Xin HY; Liu YL; Zhang JL; Xin HW; Su XL Tumour Biol; 2014 Oct; 35(10):10051-6. PubMed ID: 25015188 [TBL] [Abstract][Full Text] [Related]
10. Curcuminoid WZ35 synergize with cisplatin by inducing ROS production and inhibiting TrxR1 activity in gastric cancer cells. He W; Xia Y; Cao P; Hong L; Zhang T; Shen X; Zheng P; Shen H; Liang G; Zou P J Exp Clin Cancer Res; 2019 May; 38(1):207. PubMed ID: 31113439 [TBL] [Abstract][Full Text] [Related]
11. Enhancing conventional chemotherapy drug cisplatin-induced anti-tumor effects on human gastric cancer cells both Ma J; Hu X; Li J; Wu D; Lan Q; Wang Q; Tian S; Dong W Oncotarget; 2017 Oct; 8(49):85926-85939. PubMed ID: 29156767 [TBL] [Abstract][Full Text] [Related]
12. Spica prunellae promotes cancer cell apoptosis, inhibits cell proliferation and tumor angiogenesis in a mouse model of colorectal cancer via suppression of stat3 pathway. Lin W; Zheng L; Zhuang Q; Zhao J; Cao Z; Zeng J; Lin S; Xu W; Peng J BMC Complement Altern Med; 2013 Jun; 13():144. PubMed ID: 23800091 [TBL] [Abstract][Full Text] [Related]
13. Noscapine Increases the Sensitivity of Drug-Resistant Ovarian Cancer Cell Line SKOV3/DDP to Cisplatin by Regulating Cell Cycle and Activating Apoptotic Pathways. Shen W; Liang B; Yin J; Li X; Cheng J Cell Biochem Biophys; 2015 May; 72(1):203-13. PubMed ID: 25510462 [TBL] [Abstract][Full Text] [Related]
14. [Effect of Ferula ferulaeoides on growth and apoptosis of human gastric cancer MGC-803 transplantation tumor in nude mice]. Qiao ML; Luo JY; Yang MH; Wu JJ; Sheng P; Yang MH Zhongguo Zhong Yao Za Zhi; 2019 Jul; 44(13):2827-2834. PubMed ID: 31359697 [TBL] [Abstract][Full Text] [Related]
15. The efficacy of combination therapy using adeno-associated virus-TRAIL targeting to telomerase activity and cisplatin in a mice model of hepatocellular carcinoma. Wang Y; Huang F; Cai H; Wu Y; He G; Tan WS J Cancer Res Clin Oncol; 2010 Dec; 136(12):1827-37. PubMed ID: 20213096 [TBL] [Abstract][Full Text] [Related]
16. Enhancement of antitumor effect by intratumoral administration of bax gene in combination with anticancer drugs in gastric cancer. Kim R; Minami K; Nishimoto N; Toge T Int J Oncol; 2001 Feb; 18(2):363-7. PubMed ID: 11172605 [TBL] [Abstract][Full Text] [Related]
17. Selecting lncRNAs in gastric cancer cells for directed therapy with bioactive peptides and chemotherapy drugs. Han W; Xiao R; Zhang C; Suyila Q; Li X; Su X Oncotarget; 2017 Oct; 8(49):86082-86097. PubMed ID: 29156779 [TBL] [Abstract][Full Text] [Related]
18. Combining α-Hederin with cisplatin increases the apoptosis of gastric cancer in vivo and in vitro via mitochondrial related apoptosis pathway. Deng H; Ma J; Liu Y; He P; Dong W Biomed Pharmacother; 2019 Dec; 120():109477. PubMed ID: 31562979 [TBL] [Abstract][Full Text] [Related]
19. HO-3867, a curcumin analog, sensitizes cisplatin-resistant ovarian carcinoma, leading to therapeutic synergy through STAT3 inhibition. Selvendiran K; Ahmed S; Dayton A; Kuppusamy ML; Rivera BK; Kálai T; Hideg K; Kuppusamy P Cancer Biol Ther; 2011 Nov; 12(9):837-45. PubMed ID: 21885917 [TBL] [Abstract][Full Text] [Related]
20. Synergistic antitumor effect of AAV-mediated TRAIL expression combined with cisplatin on head and neck squamous cell carcinoma. Jiang M; Liu Z; Xiang Y; Ma H; Liu S; Liu Y; Zheng D BMC Cancer; 2011 Feb; 11():54. PubMed ID: 21291526 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]